MARC details
| 000 -LEADER |
| fixed length control field |
02987cam a2200457 a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20250919000621.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
140915s2012 enka b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781420092387 (Cloth) |
| Terms of availability |
RM554.40 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
1420092383 (Cloth) |
| 039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
| Level of rules in bibliographic description |
201409261153 |
| Level of effort used to assign nonsubject heading access points |
zainol |
| y |
09-15-2014 |
| z |
fida |
| 040 ## - CATALOGING SOURCE |
| Modifying agency |
UKM |
| Description conventions |
rda |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
QV744.D794 2012 9 |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
QV744 |
| Local cutter number (OCLC) ; Book number/undivided call number, CALL (RLIN) |
.D794 2012 9 |
| 245 00 - TITLE STATEMENT |
| Title |
Drug stereochemistry : |
| Remainder of title |
analytical methods and pharmacology / |
| Statement of responsibility, etc. |
Krzysztof J{u2BE2}zwiak, W. John Lough, Irving W. Wainer. |
| 250 ## - EDITION STATEMENT |
| Edition statement |
3rd ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Place of production, publication, distribution, manufacture |
London ; |
| -- |
New York : |
| Name of producer, publisher, distributor, manufacturer |
Informa Healthcare, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2012. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
x, 322 p. : |
| Other physical details |
illustration ; |
| Dimensions |
24 cm. |
| 336 ## - CONTENT TYPE |
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
| Media type term |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
| Carrier type term |
volume |
| Source |
rdacarrier |
| 490 1# - SERIES STATEMENT |
| Series statement |
Drugs and the pharmaceutical science series ; |
| Volume/sequential designation |
v. 211 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 520 ## - SUMMARY, ETC. |
| Summary, etc. |
'Updated to reflect modern advances in the techniques and methodology of drug stereochemistry, the Third Edition comprehensively presents all aspects of chiral drugs from scientific, academic, governmental, industrial, and clinical points of view. This stand-alone text covers the lifespan of stereochemistry, from its early history, including an overview of terms and concepts, to the current drug development process, legal and regulatory issues, and the new stereoisomeric drugs. New topics in the Third Edition include: The use of enzymes in the synthesis and resolution of enantiometrically pure compounds in drug discovery; How stereochemistry impacts decisions made in the Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) stages of drug discovery; A chapter on pharmacokinetics and pharmacodynamics that discusses the issues faced during the final stages of the drug development process; The impact of International Conference on Harmonisation on the use of single isomer drugs; Racemic switches; The concept of molecular chiral recognition and how it affects the separation and behavior of stereochemically pure drugs; A chapter on the legal perspectives of patent issues surrounding racemic switches and the marketing of single enantiomer switches'--Provided by publisher. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Chemistry, Pharmaceutical |
| General subdivision |
methods. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Molecular Conformation. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Stereoisomerism. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Pharmaceutical chemistry. |
| Source of heading or term |
fast |
| Authority record control number or standard number |
(OCoLC)fst01060115 |
| 655 #7 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Methods. |
| Source of term |
fast |
| Authority record control number or standard number |
(OCoLC)fst01423850 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Jozwiak, Krzysztof, |
| Dates associated with a name |
1971- |
| Relator term |
editor |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Lough, W. J. |
| Fuller form of name |
(W. John) |
| Relator term |
editor |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Wainer, Irving W. |
| Relator term |
editor |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
| Uniform title |
Drugs and the pharmaceutical sciences ; |
| Volume/sequential designation |
v. 211. |
| 907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) |
| a |
.b15989537 |
| b |
2019-11-12 |
| c |
2019-11-12 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Koha item type |
AM |
| Suppress in OPAC |
No |
| Call number prefix |
QV744.D794 2012 9 |
| 914 ## - VTLS Number |
| VTLS Number |
vtls003569193 |
| 990 ## - EQUIVALENCES OR CROSS-REFERENCES [LOCAL, CANADA] |
| Link information for 9XX fields |
zr |
| 991 ## - LOCAL NOTE (NAMA FAKULTI/INSTITUT/PUSAT) |
| a |
Fakulti Farmasi, KKL |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) |
| Library |
PERPUSTAKAAN DR ABDUL LATIFF |
| Operator's initials, OID (RLIN) |
2014-02-09 |
| Cataloger's initials, CIN (RLIN) |
m |
| Material Type (Sierra) |
Printed Books |
| Language |
English |
| Country |
|
| -- |
0 |
| -- |
.b15989537 |